Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect.

In conclusion, NLCs are promising nanocarriers for delivering dual chemotherapeutic drugs sequentially, showing potentials in the synergistic treatment of tumors while reducing adverse effects both in vitro and in vivo.
PMID: 32611218 [PubMed - in process]

Source: Drug Delivery - July 4, 2020 Category: Drugs & Pharmacology Tags: Drug Deliv Source Type: research